Retatrutide may become an option in the future if: Its approved by the MHRA and recommended by NICE, which is likely several years away You havent responded well to existing GLP-1 medications, and a triple agonist offers a different approach worth trying The Phase 3 safety data on heart rate, irregular heartbeats, and dysesthesia are reassuring once its complete For most people in the UK, the choice now is between Wegovy and Mounjaro, supported by a structured weight management service
As you read through HPC DataPoints, we encourage you to engage with the interactive graphics by hovering your mouse over different data points to obtain additional information
Injection technique and site rotation GLP-1 pens are injected into the abdomen, thigh or upper arm
in those who achieved at least 10% weight loss in the first year of the study)
Beginning treatment the week before a vacation or during a lighter work period allows the healing process to progress without constant re-injury
Because PCOS increases cardiovascular risk through insulin resistance and chronic inflammation, these metabolic improvements carry significant long-term health value